School of Pharmacy Partners with CET Life Sciences Center
Monday, July 07, 2008
(0 Comments)
Posted by: Matt Burchett
Cumberland Emerging Technologies, Inc. (CET) announced this week
that Belmont University has established the Belmont School of Pharmacy
Department of Pharmaceutical Sciences Laboratory at the CET Life
Sciences Center. The Life Sciences Center, which is located in downtown
Nashville, provides lab and office space, equipment and infrastructure
to early-stage biopharmaceutical ventures.
Belmont has leased the space to support research and service
programs of its School of Pharmacy. The primary objective of the lab is
to provide dosage form development, characterization and quality
analysis. The school will work with the pharmaceutical industry and
local and regional health care providers to meet previously unmet and
arising needs related to drug delivery.
"The work being performed at the Life Sciences Center is designed to
help provide drug delivery solutions, which is unique to pharmacy
practice and which, until now, has not played a major role in middle
Tennessee's robust health care scene," said Dr. Andrew Webster
(pictured above), chair and professor of pharmaceutical sciences at
Belmont's School of Pharmacy. "By partnering with CET, our faculty and
students have access to a community of resources to help advance
research that will help drug developers bring their products to
patients who need them most."
"We are delighted to welcome Belmont School of Pharmacy to our
growing roster of tenants at the Life Sciences Center," said A.J.
Kazimi, chief executive officer of Cumberland Pharmaceuticals and CET.
"Partnering with outstanding academic research and training programs
like this one is a key component of CET’s strategy, and we look forward
to providing laboratory and equipment infrastructure to support their
promising research."
Belmont's School of Pharmacy announced last week that it has
received approval from The Accreditation Council for Pharmacy Education
(ACPE) to seat its first class of 75 students for the 2008-09 academic
year.
Cumberland Emerging Technologies, Inc. (www.cet-fund.com)
is a joint initiative between Cumberland Pharmaceuticals Inc.,
Vanderbilt University and the Tennessee Technology Development
Corporation. The mission of CET is to bring biomedical technologies and
products conceived at Vanderbilt and other regional research centers to
the marketplace. CET helps manage the development and commercialization
process for select projects, and provides expertise on intellectual
property, regulatory, manufacturing and marketing issues that are
critical to successful new biomedical products. CET's Life Sciences
Center, located in Nashville, Tennessee, provides laboratory space,
equipment and infrastructure to early-stage life sciences companies.
For more stories from the Pharmacy Archive, click here.
|